9,641 Shares in The Clorox Company (NYSE:CLX) Bought by Miracle Mile Advisors LLC

Miracle Mile Advisors LLC purchased a new stake in The Clorox Company (NYSE:CLX - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 9,641 shares of the company's stock, valued at approximately $1,566,000.

Several other institutional investors have also made changes to their positions in CLX. Oppenheimer & Co. Inc. increased its holdings in Clorox by 4.0% in the 2nd quarter. Oppenheimer & Co. Inc. now owns 17,042 shares of the company's stock valued at $2,326,000 after buying an additional 659 shares during the period. DekaBank Deutsche Girozentrale boosted its position in shares of Clorox by 11.4% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 77,890 shares of the company's stock worth $10,635,000 after acquiring an additional 7,995 shares in the last quarter. Meeder Advisory Services Inc. bought a new position in Clorox in the second quarter valued at approximately $212,000. Federated Hermes Inc. raised its position in Clorox by 13.7% during the second quarter. Federated Hermes Inc. now owns 65,810 shares of the company's stock valued at $8,981,000 after purchasing an additional 7,916 shares in the last quarter. Finally, J.W. Cole Advisors Inc. lifted its stake in Clorox by 9.8% during the second quarter. J.W. Cole Advisors Inc. now owns 2,242 shares of the company's stock worth $306,000 after purchasing an additional 200 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Wells Fargo & Company upgraded Clorox from an "underweight" rating to an "equal weight" rating and lifted their price target for the company from $155.00 to $157.00 in a research note on Tuesday, January 7th. Barclays lifted their target price on Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a research report on Friday, November 1st. JPMorgan Chase & Co. boosted their target price on Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a research note on Friday, October 11th. Jefferies Financial Group upgraded shares of Clorox from a "hold" rating to a "buy" rating and raised their price target for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Finally, Evercore ISI lowered their price objective on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a research report on Monday, October 14th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Clorox presently has a consensus rating of "Hold" and a consensus price target of $157.46.

Clorox Trading Down 0.4 %

NYSE CLX traded down $0.60 on Wednesday, hitting $158.43. The company's stock had a trading volume of 602,111 shares, compared to its average volume of 965,401. The company's 50-day moving average is $164.48 and its 200 day moving average is $156.16. The firm has a market cap of $19.61 billion, a PE ratio of 55.20, a PEG ratio of 3.04 and a beta of 0.42. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox's revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.49 earnings per share. As a group, analysts predict that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.08%. Clorox's dividend payout ratio (DPR) is 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.